Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rotmensz

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1989
Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM)K Vantongelen, N Rotmensz, E van der Schueren
Annals of the New York Academy of Sciences|January 25, 2002
The Italian breast cancer prevention trial with tamoxifen: findings and new perspectivesA Guerrieri-Gonzaga, A Galli, N Rotmensz, et al.
Lancet (London, England)|April 12, 2002
Tamoxifen for breast cancer among hysterectomised womenU Veronesi, P Maisonneuve, V Sacchini, et al.
Lancet (London, England)|January 29, 1999
Drop-outs in tamoxifen prevention trialsU Veronesi, P Maisonneuve, A Costa, et al.
Minerva Medica|February 19, 2002
How to decrease the non-compliance in a clinical trialG M Baratelli, W Allio, A Lanzani, et al.
Journal of Steroid Biochemistry|December 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized EORTC study of CMF vs CMF + tamoxifenH T Mouridsen, C Rose, E Engelsmann, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifenH T Mouridsen, C Rose, E Engelsman, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative GroupR Paridaens, A Clarysse, M Rozencweig, et al.
The British Journal of Surgery|June 23, 2007
Second axillary sentinel node biopsy for ipsilateral breast tumour recurrenceM Intra, G Trifirò, V Galimberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean)M Colleoni, N Rotmensz, G Martinelli, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Cancer & Clinical Oncology|August 1, 1989
Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM)K Vantongelen, N Rotmensz, E van der Schueren
Annals of the New York Academy of Sciences|January 25, 2002
The Italian breast cancer prevention trial with tamoxifen: findings and new perspectivesA Guerrieri-Gonzaga, A Galli, N Rotmensz, et al.
Lancet (London, England)|April 12, 2002
Tamoxifen for breast cancer among hysterectomised womenU Veronesi, P Maisonneuve, V Sacchini, et al.
Lancet (London, England)|January 29, 1999
Drop-outs in tamoxifen prevention trialsU Veronesi, P Maisonneuve, A Costa, et al.
Minerva Medica|February 19, 2002
How to decrease the non-compliance in a clinical trialG M Baratelli, W Allio, A Lanzani, et al.
Journal of Steroid Biochemistry|December 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized EORTC study of CMF vs CMF + tamoxifenH T Mouridsen, C Rose, E Engelsmann, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifenH T Mouridsen, C Rose, E Engelsman, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative GroupR Paridaens, A Clarysse, M Rozencweig, et al.
The British Journal of Surgery|June 23, 2007
Second axillary sentinel node biopsy for ipsilateral breast tumour recurrenceM Intra, G Trifirò, V Galimberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean)M Colleoni, N Rotmensz, G Martinelli, et al.
Pageof 10